TP
TMO icon

Tranquility Partners’s Thermo Fisher Scientific TMO Stock Holding History

Tranquility Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$838K Sell
1,705
-57
-3% -$30.9K 0.32% 81
2025
Q4 		$1.02M Sell
1,762
-465
-21% -$263K 0.37% 67
2025
Q3 		$1.08M Sell
2,227
-533
-19% -$248K 0.36% 69
2025
Q2 		$1.12M Buy
2,760
+498
+22% +$208K 0.4% 70
2025
Q1 		$1.13M Buy
2,262
+23
+1% +$12.5K 0.43% 65
2024
Q4 		$1.16M Sell
2,239
-105
-4% -$57.7K 0.44% 64
2024
Q3 		$1.45M Sell
2,344
-11
-0.5% -$6.51K 0.53% 49
2024
Q2 		$1.3M Buy
2,355
+355
+18% +$203K 0.5% 52
2024
Q1 		$1.16M Sell
2,000
-9
-0.4% -$5.05K 0.45% 60
2023
Q4 		$1.07M Buy
2,009
+515
+34% +$249K 0.45% 60
2023
Q3 		$756K Sell
1,494
-62
-4% -$33K 0.32% 81
2023
Q2 		$812K Sell
1,556
-8
-0.5% -$4.32K 0.35% 79
2023
Q1 		$901K Sell
1,564
-4
-0.3% -$2.25K 0.43% 66
2022
Q4 		$863K Buy
1,568
+20
+1% +$10.6K 0.44% 65
2022
Q3 		$785K Buy
1,548
+17
+1% +$9.51K 0.44% 66
2022
Q2 		$832K Buy
1,531
+481
+46% +$265K 0.43% 66
2022
Q1 		$620K Hold
1,050
– – 0.29% 96
2021
Q4 		$701K Hold
1,050
– – 0.32% 85
2021
Q3 		$600K Buy
1,050
+60
+6% +$32.9K 0.3% 91
2021
Q2 		$499K Sell
990
-46
-4% -$21.7K 0.28% 100
2021
Q1 		$473K Sell
1,036
-482
-32% -$230K 0.29% 101
2020
Q4 		$707K Hold
1,518
– – 0.5% 69
2020
Q3 		$670K Buy
1,518
+227
+18% +$93.8K 0.57% 58
2020
Q2 		$468K Hold
1,291
– – 0.44% 72
2020
Q1 		$366K Sell
1,291
-60
-4% -$18.9K 0.42% 70
2019
Q4 		$439K Hold
1,351
– – 0.4% 82
2019
Q3 		$394K Hold
1,351
– – 0.42% 79
2019
Q2 		$397K Buy
+1,351
New +$372K 0.43% 76

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tranquility Partners's TMO Position: Q1 2026 in Review

Tranquility Partners reduced its Thermo Fisher Scientific (TMO) stake by 3.2% in Q1 2026, selling an estimated $30.9K and leaving 1,705 shares worth $838K. The position accounts for 0.32% of the portfolio, ranked #81.

Tranquility Partners first reported a position in TMO in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.45M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Tranquility Partners held 1,705 shares of Thermo Fisher Scientific worth $838K as of Q1 2026.
  • Tranquility Partners sold 57 Thermo Fisher Scientific shares in Q1 2026, an estimated $30.9K.
  • Thermo Fisher Scientific made up 0.32% of Tranquility Partners's portfolio in Q1 2026, its #81 holding.
  • Tranquility Partners first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 28 quarters since.
  • Tranquility Partners's Thermo Fisher Scientific position peaked at $1.45M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Tranquility Partners's 13F filing for Q1 2026, filed 20 Apr 2026.